Peroxisome proliferator-activated receptor γ (PPARγ) is a transcriptional coactivator that
binds to a diverse range of transcription factors. PPARγ coactivator 1 (PGC-1) coactivators …

Three Duchenne muscular dystrophy (DMD) patients received injections of myogenic cells
obtained from skeletal muscle biopsies of normal donors. The cells (30× 10 6) were injected …

Objectives: The goal of this study is to characterize resident cardiac stem cells (CSCs) and
investigate their therapeutic efficacy in myocardial infarction by molecular imaging methods …

Myotonic dystrophy (DM) is the most common form of muscular dystrophy and is caused by
expansion of a CTG trinucleotide repeat on human chromosome 19. Patients with DM …

Duchenne muscular dystrophy (DMD) is a genetic muscle disorder caused by mutations in
the Dmd gene resulting in the loss of the protein dystrophin. Patients do not only experience …

Erythropoietin (Epo)-responsive anemia is a common and debilitating complication of
chronic renal failure and human immunodeficiency virus infection. Current therapy for this …

Duchenne muscular dystrophy is one of the most common inherited genetic diseases and is
caused by mutations to the DMD gene that encodes the dystrophin protein. Recent …

Severe injury to the skeletal muscle often results in the formation of scar tissue, leading to a
decline in functional performance. Traditionally, tissue engineering strategies for muscle …

The genetic basis of many muscular disorders, including many of the more common
muscular dystrophies, is now known. Clinically, the recent genetic advances have improved …

We have assessed the reliability of hand‐held myometry in 33 patients with spinal muscular
atrophy (SMA), testing elbow flexion, handgrip, three‐point pinch, knee flexion, knee …